T1	Participants 546 622	665 patients with a history of colorectal adenomas to three treatment groups
T2	Participants 904 1038	23 patients died, 15 were lost to follow-up, 45 refused repeat colonoscopy, and five developed severe contraindications to colonoscopy
T3	Participants 1050 1134	552 participants who completed the follow-up examination, 94 stopped treatment early
T4	Participants 1170 1299	28 (15.9%) of 176 patients in the calcium group, 58 (29.3%) of 198 in the fibre group, and 36 (20.2%) of 178 in the placebo group
T5	Participants 1803 1844	patients with high dietary calcium intake
